| Literature DB >> 9436462 |
N G Singer1, R Mitra, F Lialios, B C Richardson, R M Marks, J M Pesando, D A Fox, B J Nickoloff.
Abstract
The CD6 glycoprotein is expressed by T lymphocytes and is hypothesized to interact with one or more ligands expressed on antigen presenting cells (APCs). We show that CD6 mediates binding of the transformed CD4+ T cell line Hut 78 to gamma-interferon activated keratinocytes (KCs). A recombinant CD6-Ig fusion protein has been reported to bind to a CD6 ligand ALCAM, but this is the first demonstration that cell-cell adhesion of human T lymphocytes can be CD6 dependent. The known CD6 ligand ALCAM (CD166) is expressed on cultured KCs but does not appear to mediate KC-Hut 78 binding, suggesting the existence of additional CD6 ligands expressed on KCs. In functional studies using autologous KCs as APCs for tetanus toxoid specific T cell clones, KCs +/- gamma-interferon are unable to stimulate autologous T cells with recall antigen. Therefore interaction of T cell CD6 with CD6 ligands on KCs does not provide sufficient co-stimulation of primed T cells to support responses to nominal antigen.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9436462 DOI: 10.1016/s0165-2478(97)02707-7
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685